351 related articles for article (PubMed ID: 20662275)
1. [Front line of oxidized lipoproteins: role of oxidized lipoproteins in atherogenesis and cardiovascular disease risk].
Yoshida H
Rinsho Byori; 2010 Jun; 58(6):622-30. PubMed ID: 20662275
[TBL] [Abstract][Full Text] [Related]
2. Comparative Analysis of Atherogenic Lipoproteins L5 and Lp(a) in Atherosclerotic Cardiovascular Disease.
Akyol O; Yang CY; Woodside DG; Chiang HH; Chen CH; Gotto AM
Curr Atheroscler Rep; 2024 Jul; 26(7):317-329. PubMed ID: 38753254
[TBL] [Abstract][Full Text] [Related]
3. Oxysterols in Vascular Cells and Role in Atherosclerosis.
Luquain-Costaz C; Delton I
Adv Exp Med Biol; 2024; 1440():213-229. PubMed ID: 38036882
[TBL] [Abstract][Full Text] [Related]
4. The role of oxidized low-density lipoproteins in atherosclerosis: the myths and the facts.
Maiolino G; Rossitto G; Caielli P; Bisogni V; Rossi GP; Calò LA
Mediators Inflamm; 2013; 2013():714653. PubMed ID: 24222937
[TBL] [Abstract][Full Text] [Related]
5. HDL Function and Atherosclerosis: Reactive Dicarbonyls as Promising Targets of Therapy.
Linton MF; Yancey PG; Tao H; Davies SS
Circ Res; 2023 May; 132(11):1521-1545. PubMed ID: 37228232
[TBL] [Abstract][Full Text] [Related]
6. Lipoproteins, Cholesterol, and Atherosclerotic Cardiovascular Disease in East Asians and Europeans.
Doi T; Langsted A; Nordestgaard BG
J Atheroscler Thromb; 2023 Nov; 30(11):1525-1546. PubMed ID: 37704428
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein Assessment in the twenty-first Century.
Lucero D; Wolska A; Aligabi Z; Turecamo S; Remaley AT
Endocrinol Metab Clin North Am; 2022 Sep; 51(3):459-481. PubMed ID: 35963624
[TBL] [Abstract][Full Text] [Related]
8. We Must Abandon the Myth: Oxidized Low-density Lipoprotein is not a Lipoprotein that Plays a Key Role in Atherogenesis.
Orekhov AN
Curr Med Chem; 2024 Mar; ():. PubMed ID: 38494931
[TBL] [Abstract][Full Text] [Related]
9. Differences in Structural Changes and Pathophysiological Effects of Low-Density Lipoprotein Particles upon Accumulation of Acylhydroperoxy Derivatives in Their Outer Phospholipid Monolayer or upon Modification of Apoprotein B-100 by Natural Dicarbonyls.
Lankin VZ; Tikhaze AK; Konovalova GG
Biochemistry (Mosc); 2023 Nov; 88(11):1910-1919. PubMed ID: 38105208
[TBL] [Abstract][Full Text] [Related]
10. Apolipoproteins as potential communicators play an essential role in the pathogenesis and treatment of early atherosclerosis.
Li Y; Luo X; Hua Z; Xue X; Wang X; Pang M; Wang T; Lyu A; Liu Y
Int J Biol Sci; 2023; 19(14):4493-4510. PubMed ID: 37781031
[TBL] [Abstract][Full Text] [Related]
11. The Atherogenic Role of Circulating Modified Lipids in Atherosclerosis.
Summerhill VI; Grechko AV; Yet SF; Sobenin IA; Orekhov AN
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31330845
[TBL] [Abstract][Full Text] [Related]
12. Modified low density lipoprotein and lipoprotein-containing circulating immune complexes as diagnostic and prognostic biomarkers of atherosclerosis and type 1 diabetes macrovascular disease.
Orekhov AN; Bobryshev YV; Sobenin IA; Melnichenko AA; Chistiakov DA
Int J Mol Sci; 2014 Jul; 15(7):12807-41. PubMed ID: 25050779
[TBL] [Abstract][Full Text] [Related]
13. Regulation of cardiovascular calcification by lipids and lipoproteins.
Hsu JJ; Tintut Y; Demer LL
Curr Opin Lipidol; 2022 Oct; 33(5):289-294. PubMed ID: 35979985
[TBL] [Abstract][Full Text] [Related]
14. In vitro interactions of extracellular histones with LDL suggest a potential pro-atherogenic role.
Pemberton AD; Brown JK
PLoS One; 2010 Mar; 5(3):e9884. PubMed ID: 20360839
[TBL] [Abstract][Full Text] [Related]
15. Oxidized low-density lipoprotein in inflammation-driven thrombosis.
Obermayer G; Afonyushkin T; Binder CJ
J Thromb Haemost; 2018 Mar; 16(3):418-428. PubMed ID: 29316215
[TBL] [Abstract][Full Text] [Related]
16. The LDL-HDL profile determines the risk of atherosclerosis: a mathematical model.
Hao W; Friedman A
PLoS One; 2014; 9(3):e90497. PubMed ID: 24621857
[TBL] [Abstract][Full Text] [Related]
17. Oxidative Stress, Atherogenic Dyslipidemia, and Cardiovascular Risk.
Vekic J; Stromsnes K; Mazzalai S; Zeljkovic A; Rizzo M; Gambini J
Biomedicines; 2023 Oct; 11(11):. PubMed ID: 38001900
[TBL] [Abstract][Full Text] [Related]
18. Highlighting Residual Atherosclerotic Cardiovascular Disease Risk.
Matsuura Y; Kanter JE; Bornfeldt KE
Arterioscler Thromb Vasc Biol; 2019 Jan; 39(1):e1-e9. PubMed ID: 30586334
[No Abstract] [Full Text] [Related]
19. Predictive utility of remnant cholesterol in atherosclerotic cardiovascular disease.
Proctor SD; Wang M; Vine DF; Raggi P
Curr Opin Cardiol; 2024 Jul; 39(4):300-307. PubMed ID: 38456429
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
